Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dose Ranging Effects of Three Low-doses of Naturlose™ (Tagatose) on Glycemic Control and Safety of Naturlose™ (Tagatose) Over Six Months in Subjects With Mild Type 2 Diabetes Mellitus Under Control With Diet and Exercise.

NCT00961662 is registered in ClinicalTrials.gov with Robert Lodder as lead sponsor.

NCT NCT00961662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00961662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dose Ranging Effects of Three Low-doses of Naturlose™ (Tagatose) on Glycemic Control and Safety of Naturlose™ (Tagatose) Over Six Months in Subjects With Mild Type 2 Diabetes Mellitus Under Control With Diet and Exercise.
Lead sponsor
Robert Lodder
Phase
Phase 2
Overall status
Completed
Start date
February 29, 2008
Completion date
August 31, 2010
Enrollment
161 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes